Vietnam Interventional Cardiology Market - Industry Trends and Forecast to 2028

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 OVERVIEW OF VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET 13
1.4 LIMITATIONS 14
1.5 MARKETS COVERED 15
2 MARKET SEGMENTATION 17
2.1 MARKETS COVERED 17
2.2 GEOGRAPHICAL SCOPE 18
2.3 YEARS CONSIDERED FOR THE STUDY 19
2.4 CURRENCY AND PRICING 19
2.5 DBMR TRIPOD DATA VALIDATION MODEL 20
2.6 MULTIVARIATE MODELLING 23
2.7 PRODUCT LIFELINE CURVE 23
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 24
2.9 DBMR MARKET POSITION GRID 25
2.10 MARKET APPLICATION COVERAGE GRID 26
2.11 VENDOR SHARE ANALYSIS 27
2.12 SECONDARY SOURCES 28
2.13 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 32
4.1 PESTEL ANALYSIS 33
4.2 PORTERS FIVE FORCES MODEL 34
4.3 CORONARY INTERVENTION CARDIOLOGY (CVI) AND PERIPHERAL VASCULAR INTERVENTION (PVI) PROCEDURE (TOTAL CASES IN VIETNAM), 2019- 2028 (UNIT) 34
4.4 CORONARY INTERVENTION CARDIOLOGY (CVI) AND PERIPHERAL VASCULAR INTERVENTION (PVI) PROCEDURE (CASES IN TOP 10 HOSPITALS), 2019- 2028 (UNIT) 35
5 INDUSTRY INSIGHTS 37
5.1 STENT AND BALLOON BUSINESS TRENDS 37
5.1.1 OVERVIEW 37
6 VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, REGULATORY FRAMEWORK 38
6.1 VIETNAM 38
7 MARKET OVERVIEW 40
7.1 DRIVERS 42
7.1.1 HIGH PREVALENCE OF CARDIOVASCULAR DISEASES 42
7.1.2 INCREASED RESEARCH AND DEVELOPMENT 42
7.1.3 RISING GERIATRIC POPULATION 42
7.1.4 RISE IN THE NUMBER OF INTERVENTIONAL CARDIOLOGY 43
7.1.5 RISE IN RATES OF OBESITY 44
7.2 RESTRAINTS 44
7.2.1 COMPLICATIONS ASSOCIATED WITH INTERVENTIONAL CARDIOLOGY PROCEDURES 44
7.2.2 HIGH COST OF INTERVENTIONAL CARDIOLOGY PRODUCTS 45
7.3 OPPORTUNITIES 45
7.3.1 RISE IN EXPENDITURE ON HEALTHCARE 45
7.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 46
7.3.3 RISE IN DEMAND FOR MINIMALLY INVASIVE TECHNOLOGY 46
7.4 CHALLENGES 47
7.4.1 LOW AWARENESS FOR CVD AND ITS INTERVENTIONS 47
7.4.2 SHORTAGE OF SKILLED PROFESSIONALS 47
8 IMPACT OF COVID-19 ON VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET 49
8.1 OVERVIEW 49
8.2 IMPACT ON PRICE 49
8.3 IMPACT ON DEMAND 50
8.4 IMPACT ON SUPPLY 50
8.5 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS 50
8.6 CONCLUSION 51
9 VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, BY PRODUCT 52
9.1 OVERVIEW 53
9.2 CATHETERS 56
9.2.1 ANGIOGRAPHY CATHETERS 56
9.2.2 BALLOON DILATATION CATHETERS 56
9.2.3 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) GUIDING CATHETERS 57
9.2.4 GUIDE EXTENSION CATHETERS 57
9.2.5 MICROCATHETERS 57
9.2.6 DUAL LUMEN CATHETERS 57
9.2.7 OTHERS 57
9.3 GUIDE WIRES 57
9.3.1 CORONARY GUIDE WIRES 58
9.3.2 SPECIALTY GUIDE WIRES 58
9.4 CORONARY STENTS 58
9.4.1 BARE STENTS 59
9.4.2 DRUG-ELUTING STENTS 59
9.4.3 BIO ABSORBABLE STENTS 59
9.5 ANGIOPLASTY BALLOONS 59
9.5.1 OLD/NORMAL BALLOONS 60
9.5.2 DRUG-ELUTING BALLOONS 60
9.5.3 CUTTING/SCORING BALLOONS 60
9.6 PLAGUE MODIFICATION DEVICES 60
9.6.1 THROMBECTOMY DEVICES 61
9.6.2 ATHERECTOMY 61
9.7 HEMODYNAMIC FLOW ALTERATION DEVICES 61
9.7.1 EMBOLIC PROTECTION DEVICES 61
9.7.2 CHRONIC TOTAL OCCLUSION DEVICES 61
9.8 VASCULAR CLOSURE DEVICES (VCDS) 62
9.9 NITINOL CLIP-BASED (STARCLOSE) DEVICES 62
9.10 SUTURE BASED (PERCLOSE) 62
9.11 COLLAGEN PLUG-BASED (ANGIO-SEAL) 62
9.12 FRACTIONAL FLOW RESERVE (FFR) 63
9.13 ACCESSORIES 63
9.14 ANGIOPLASTY KITS 63
9.15 BALLOON INFLATION DEVICES 63
9.16 INTRODUCER SHEATHS 63
9.17 HEMOSTASIS HEART 64
9.18 OTHERS 64
10 VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, BY TYPE 65
10.1 OVERVIEW 66
10.2 CONVENTIONAL 68
10.2.1 CATHETERS 69
10.2.2 CORONARY GUIDE WIRES 69
10.2.3 CORONARY STENTS 69
10.2.4 VASCULAR CLOSURE DEVICES (VCDS) 69
10.2.5 OTHERS 69
10.3 ADVANCED 69
10.3.1 PLAGUE MODIFICATION DEVICES 70
10.3.2 HEMODYNAMIC FLOW ALTERATION DEVICES 70
10.3.3 INTRAVASCULAR ULTRASOUND (IVUS) CATHETERS 70
10.3.4 FRACTIONAL FLOW RESERVE (FFR) 70
11 VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, BY INDICATION 71
11.1 OVERVIEW 72
11.2 CARDIAC CATHETERIZATION 75
11.3 PERCUTANEOUS CORONARY INTERVENTION (PCI) 75
11.4 CORONARY THROMBECTOMY 75
11.5 ATHERECTOMY 76
11.6 BALLOON ANGIOPLASTY 76
11.7 STENT IMPLANTATION 76
11.8 HYPOTHERMIA/INTRA-AORTIC BALLOON PUMP 76
11.9 PATENT FORAMEN OVALE CLOSURE 77
11.10 OTHERS 77
12 VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, BY AGE 78
12.1 OVERVIEW 79
12.2 ADULT 81
12.3 PEDIATRIC 82
12.4 GERIATRIC 82
13 VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, BY END USER 83
13.1 OVERVIEW 84
13.2 HOSPITALS 86
13.2.1 ACUTE CARE HOSPITALS 87
13.2.2 LONG-TERM CARE HOSPITALS 87
13.3 CATH LABORATORIES 87
13.4 ACADEMIC & RESEARCH INSTITUTES 88
13.5 OTHERS 88
14 VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, BY DISTRIBUTION CHANNEL 89
14.1 OVERVIEW 90
14.2 DIRECT TENDERS 93
14.3 THIRD PARTY DISTRIBUTORS 93
15 VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET: COMPANY LANDSCAPE 94
15.1 COMPANY SHARE ANALYSIS: VIETNAM 94
16 SWOT ANALYSIS 95
17 COMPANY PROFILE 96
17.1 BOSTON SCIENTIFIC CORPORATION 96
17.1.1 COMPANY SNAPSHOT 96
17.1.2 REVENUE FINANCIALS 97
17.1.3 PRODUCT PORTFOLIO 97
17.1.4 RECENT DEVELOPMENTS 98
17.2 TERUMO VIETNAM MEDICAL EQUIPMENTS CO.,LTD (A SUBSIDIARY OF TERUMO CORPORATION) 100
17.2.1 COMPANY SNAPSHOT 100
17.2.2 REVENUE ANALYSIS 100
17.2.3 PRODUCT PORTFOLIO 101
17.2.4 RECENT DEVELOPMENTS 101
17.3 ABBOTT 103
17.3.1 COMPANY SNAPSHOT 103
17.3.2 REVENUE ANALYSIS 103
17.3.3 PRODUCT PORTFOLIO 104
17.3.4 RECENT DEVELOPMENTS 106
17.4 MEDTRONIC 107
17.4.1 COMPANY SNAPSHOT 107
17.4.2 REVENUE FINANCIALS 107
17.4.3 PRODUCT PORTFOLIO 108
17.4.4 RECENT DEVELOPMENTS 109
17.5 STRYKER 111
17.5.1 COMPANY SNAPSHOT 111
17.5.2 REVENUE ANALYSIS 111
17.5.3 PRODUCT PORTFOLIO 112
17.5.4 RECENT DEVELOPMENTS 112
17.6 BD 113
17.6.1 COMPANY SNAPSHOT 113
17.6.2 REVENUE ANALYSIS 113
17.6.3 PRODUCT PORTFOLIO 114
17.6.4 RECENT DEVELOPMENTS 114
17.7 ANGIO DYNAMICS 115
17.7.1 COMPANY SNAPSHOT 115
17.7.2 REVENUE FINANCIALS 115
17.7.3 PRODUCT PORTFOLIO 116
17.7.4 RECENT DEVELOPMENTS 116
17.8 B. BRAUN MELSUNGEN AG 117
17.8.1 COMPANY SNAPSHOT 117
17.8.2 REVENUE ANALYSIS 117
17.8.3 PRODUCT PORTFOLIO 118
17.8.4 1.8.4 RECENT DEVELOPMENTS 118
17.9 BIOTRONIK 119
17.9.1 COMPANY SNAPSHOT 119
17.9.2 PRODUCT PORTFOLIO 119
17.9.3 RECENT DEVELOPMENTS 120
17.10 MEDINOL LTD. 121
17.10.1 COMPANY SNAPSHOT 121
17.10.2 PRODUCT PORTFOLIO 121
17.10.3 RECENT DEVELOPMENT 121
17.11 PHLIPS ELECTRONICS N.V. (A SUBSIDIARY OF KONINKLIJKE PHILIPS N.V.) 122
17.11.1 COMPANY SNAPSHOT 122
17.11.2 REVENUE ANALYSIS 122
17.11.3 PRODUCT PORTFOLIO 123
17.11.4 RECENT DEVELOPMENTS 123
17.12 TELEFLEX INCORPORATED 124
17.12.1 COMPANY SNAPSHOT 124
17.12.2 REVENUE ANALYSIS 124
17.12.3 PRODUCT PORTFOLIO 125
17.12.4 RECENT DEVELOPMENTS 125
17.13 USM HEALTHCARE 126
17.13.1 COMPANY SNAPSHOT 126
17.13.2 PRODUCT PORTFOLIO 126
17.13.3 RECENT DEVELOPMENT 127
18 QUESTIONNAIRE 128
19 RELATED REPORTS 132